SU11657 (SUGEN) is a selective multitargeted (class III/V) tyrosine kinase inhibitor with anti-tumor and anti-angiogenic activity exerted by targeting PDGFR, VEGFR, SCF receptor (c-Kit), and FMS-related tyrosine kinase 3. The gene discussed is FLT3; the disease is neoplasm.